e-learning
resources
Munich 2006
Wednesday 06.09.2006
New investigational approaches to smoking and smoking cessation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD
P. Rytilä, H. Ilumets, M. Myllärniemi, A. Sovijärvi, V. L. Kinnula (Helsinki, Finland)
Source:
Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Session:
New investigational approaches to smoking and smoking cessation
Session type:
Oral Presentation
Number:
4623
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Rytilä, H. Ilumets, M. Myllärniemi, A. Sovijärvi, V. L. Kinnula (Helsinki, Finland). 8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD. Eur Respir J 2006; 28: Suppl. 50, 4623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD
Source: Eur Respir J 2007; 29: 51-55
Year: 2007
Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005
The role of inflammation in COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Implications for disease and therapy
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke
Source: Eur Respir J 2012; 39: 254-264
Year: 2012
Oxidative stress and airway inflammation in healthy smokers and COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
Senescence marker protein-30 decreases oxidative stress in human lungs of smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Oxidative stress in patients with COPD and pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 161s
Year: 2006
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013
Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept